Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine

被引:26
作者
Grözinger, M [1 ]
Dragicevic, A [1 ]
Hiemke, C [1 ]
Shams, M [1 ]
Müller, MJ [1 ]
Härtter, S [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Psychiat, Neurochem Lab, D-55131 Mainz, Germany
关键词
D O I
10.1055/s-2003-38084
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Melperone, a butyrophenone neuroleptic, is frequently used for its sleep-inducing properties. Despite its common use for more than 30 years, it is not yet characterized regarding its effects on cytochrome P450 s (CYPs). In an open pilot study, effects of melperone on the steady-state blood levels of venlafaxine, a recently introduced serotonin- and noradrenaline reuptake inhibiting antidepressant, were assessed. Methods: The dose-corrected serum concentrations of venlafaxine and O-desmethylvenlafaxine were analyzed retrospectively in a therapeutic drug-monitoring (TDM) database comprising 94 patients. In addition, three patients received venlafaxine and melperone concomitantly and the serum concentrations of venlafaxine and O-desmethylvenlafaxine were analyzed before, during, and after melperone co-medication. The effect of melperone on CYP2D6 was further assessed in seven patients by means of the dextromethorphan O-demethylation, which serves as a CYP2D6 probe reaction. Results: Patients treated concomitantly with venlafaxine and melperone had significantly higher (mean +/- SD) venlafaxine (3.27 +/- 2.9 vs. 0.97 +/- 0.99 ng/ml per mg/d; p < 0.05) and lower O-desmethylvenlafaxine serum concentrations (0.69 +/- 0.35 vs. 1.51 +/- 0.9 ng/ml per mg/d; p < 0.01) compared to patients without melperone comedication. in the three patients, venlafaxine serum concentrations increased, on average by 52% during melperone co-medication, whereas O-desmethylvenlafaxine was decreased, on average by 29%. Administration of melperone over three days elevated the ratio of dextromethorphan to dextrorphan from 0.044 +/- 0.04 to 0.09 +/- 0.083 (p < 0.05). Discussion: This study pointed to an inhibitory effect of melperone on the O-demethylation of venlafaxine. Because the O-demethylation of venlafaxine is almost exclusively catalyzed by CYP2D6 it is concluded that melperone is an inhibitor of CYP2D6. The hypothesis was further corroborated by the inhibitory effect of melperone on the dextromethorphan O-demethylation.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 26 条
[1]  
BENKERT O, 2001, KOMPENDIUM PSYCHIATR
[2]   DOUBLE-BLIND COMPARISON OF MELPERONE AND THIOTHIXENE IN PSYCHOTIC WOMEN USING A NEW RATING-SCALE, CPRS [J].
BJERKENSTEDT, L ;
GULLBERG, B ;
HARNRYD, C ;
GRIMM, V ;
SEDVALL, G .
ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1978, 226 (03) :157-172
[3]  
Bjerkenstedt L, 1989, Acta Psychiatr Scand Suppl, V352, P35
[4]   THE S-DEFICIENCY HYPOTHESIS OF DEPRESSION AND THE 2-PROCESS MODEL OF SLEEP REGULATION [J].
BORBELY, AA .
PHARMACOPSYCHIATRY, 1987, 20 (01) :23-29
[5]   PHARMACOKINETICS OF PARENTERAL AND ORAL MELPERONE IN MAN [J].
BORGSTROM, L ;
LARSSON, H ;
MOLANDER, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (02) :173-176
[6]  
CHRISTENSEN I, 1986, ARZNEIMITTEL-FORSCH, V36-1, P855
[7]  
Christensson E G, 1989, Acta Psychiatr Scand Suppl, V352, P7
[8]   Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: A case report [J].
Eap, CB ;
Bertel-Laubscher, R ;
Zullino, D ;
Amey, M ;
Baumann, P .
PHARMACOPSYCHIATRY, 2000, 33 (03) :112-115
[9]   O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells:: Effect of metabolic inhibitors and SSRI antidepressants [J].
Fogelman, SM ;
Schmider, J ;
Venkatakrishnan, K ;
von Moltke, LL ;
Harmatz, JS ;
Shader, RI ;
Greenblatt, DJ .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (05) :480-490
[10]   Sleep disturbances and mood disorders: An epidemiologic perspective [J].
Ford, DE ;
Cooper-Patrick, L .
DEPRESSION AND ANXIETY, 2001, 14 (01) :3-6